MetLife Investment Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170K | Buy |
45,596
+23,716
| +108% | +$88.5K | ﹤0.01% | 2274 |
|
|
2025
Q1 | $60.4K | Sell |
21,880
-21,880
| -50% | -$60.4K | ﹤0.01% | 2669 |
|
|
2024
Q4 | $242K | Buy |
43,760
+9,500
| +28% | +$52.6K | ﹤0.01% | 2202 |
|
|
2024
Q3 | $286K | Hold |
34,260
| – | – | ﹤0.01% | 2091 |
|
|
2024
Q2 | $233K | Buy |
34,260
+11,148
| +48% | +$75.9K | ﹤0.01% | 2150 |
|
|
2024
Q1 | $152K | Hold |
23,112
| – | – | ﹤0.01% | 2340 |
|
|
2023
Q4 | $150K | Hold |
23,112
| – | – | ﹤0.01% | 2396 |
|
|
2023
Q3 | $116K | Hold |
23,112
| – | – | ﹤0.01% | 2502 |
|
|
2023
Q2 | $202K | Buy |
+23,112
| New | +$202K | ﹤0.01% | 2271 |
|